pd 153035 has been researched along with Adjuvant Arthritis in 1 studies
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline: structure given in first source
PD-153035 : A member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Swanson, CD | 1 |
| Akama-Garren, EH | 1 |
| Stein, EA | 1 |
| Petralia, JD | 1 |
| Ruiz, PJ | 1 |
| Edalati, A | 1 |
| Lindstrom, TM | 1 |
| Robinson, WH | 1 |
1 other study available for pd 153035 and Adjuvant Arthritis
| Article | Year |
|---|---|
Inhibition of epidermal growth factor receptor tyrosine kinase ameliorates collagen-induced arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Becaplermin; Cell Division; Cyclooxygenase | 2012 |